November 25, 2024 - 22:01
IceCure Medical Ltd. has announced that its next-generation multiprobe cryoablation technology has received a Notice of Allowance from Japan's Patent Office. This significant development marks a key milestone for the company's innovative approach to minimally invasive medical procedures.
The multiprobe cryoablation technology is designed to enhance the effectiveness and efficiency of cryoablation treatments, which are used to destroy abnormal tissues through extreme cold. This advancement is expected to provide physicians with improved tools for treating various medical conditions, potentially leading to better patient outcomes.
The approval from Japan's Patent Office underscores the technological advancements that IceCure is bringing to the field of cryoablation, positioning the company for growth in the competitive medical technology market.
August 13, 2025 - 17:36
Insights from NIH Director on mRNA Technology and FundingIn a recent interview, the director of the National Institutes of Health, Jay Bhattacharya, shared valuable insights regarding the advancements in mRNA technology and its implications for future...
August 13, 2025 - 00:35
AI Startup Makes Bold Move to Acquire Google ChromeIn a surprising turn of events, an AI startup has made an unsolicited bid to acquire Google Chrome, marking its second significant offer this year for a major tech asset. Earlier in January, the...
August 12, 2025 - 11:40
James Kenigsberg Takes on Role of Interim Chief Innovation and Technology OfficerAmerican Public Education, Inc. has appointed James Kenigsberg as its interim Chief Innovation and Technology Officer, marking a significant shift in its leadership structure. Kenigsberg brings a...
August 11, 2025 - 19:27
Teachers Find New Inspiration in Science and Technology at ERDCVICKSBURG, Miss. — At six of the U.S. Army Engineer Research and Development Center’s (ERDC) seven laboratories, 18 teachers are returning to their classrooms with a renewed passion for science...